nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—asthma—atopic dermatitis	0.816	1	CtDrD
Isoprenaline—Sweating—Desonide—atopic dermatitis	0.00103	0.0203	CcSEcCtD
Isoprenaline—Ventricular arrhythmia—Tacrolimus—atopic dermatitis	0.000994	0.0197	CcSEcCtD
Isoprenaline—Hyperhidrosis—Desonide—atopic dermatitis	0.00066	0.0131	CcSEcCtD
Isoprenaline—Pulmonary oedema—Tacrolimus—atopic dermatitis	0.000655	0.013	CcSEcCtD
Isoprenaline—Flushing—Pimecrolimus—atopic dermatitis	0.00063	0.0125	CcSEcCtD
Isoprenaline—Tension—Diphenhydramine—atopic dermatitis	0.0006	0.0119	CcSEcCtD
Isoprenaline—Tension—Dimenhydrinate—atopic dermatitis	0.0006	0.0119	CcSEcCtD
Isoprenaline—Nervousness—Diphenhydramine—atopic dermatitis	0.000594	0.0118	CcSEcCtD
Isoprenaline—Nervousness—Dimenhydrinate—atopic dermatitis	0.000594	0.0118	CcSEcCtD
Isoprenaline—Vision blurred—Dimenhydrinate—atopic dermatitis	0.000576	0.0114	CcSEcCtD
Isoprenaline—Vision blurred—Diphenhydramine—atopic dermatitis	0.000576	0.0114	CcSEcCtD
Isoprenaline—Tremor—Dimenhydrinate—atopic dermatitis	0.000573	0.0114	CcSEcCtD
Isoprenaline—Tremor—Diphenhydramine—atopic dermatitis	0.000573	0.0114	CcSEcCtD
Isoprenaline—Bronchospasm—Mometasone—atopic dermatitis	0.00057	0.0113	CcSEcCtD
Isoprenaline—Vertigo—Dimenhydrinate—atopic dermatitis	0.000549	0.0109	CcSEcCtD
Isoprenaline—Vertigo—Diphenhydramine—atopic dermatitis	0.000549	0.0109	CcSEcCtD
Isoprenaline—Palpitations—Dimenhydrinate—atopic dermatitis	0.00054	0.0107	CcSEcCtD
Isoprenaline—Palpitations—Diphenhydramine—atopic dermatitis	0.00054	0.0107	CcSEcCtD
Isoprenaline—Convulsion—Diphenhydramine—atopic dermatitis	0.00053	0.0105	CcSEcCtD
Isoprenaline—Convulsion—Dimenhydrinate—atopic dermatitis	0.00053	0.0105	CcSEcCtD
Isoprenaline—Cardiac arrest—Tacrolimus—atopic dermatitis	0.000508	0.0101	CcSEcCtD
Isoprenaline—PIK3R2—head—atopic dermatitis	0.000506	0.246	CbGeAlD
Isoprenaline—Tachycardia—Dimenhydrinate—atopic dermatitis	0.000487	0.00965	CcSEcCtD
Isoprenaline—Tachycardia—Diphenhydramine—atopic dermatitis	0.000487	0.00965	CcSEcCtD
Isoprenaline—Arrhythmia—Loratadine—atopic dermatitis	0.000483	0.00958	CcSEcCtD
Isoprenaline—Hyperhidrosis—Diphenhydramine—atopic dermatitis	0.000482	0.00956	CcSEcCtD
Isoprenaline—Hyperhidrosis—Dimenhydrinate—atopic dermatitis	0.000482	0.00956	CcSEcCtD
Isoprenaline—Hypotension—Dimenhydrinate—atopic dermatitis	0.000466	0.00924	CcSEcCtD
Isoprenaline—Hypotension—Diphenhydramine—atopic dermatitis	0.000466	0.00924	CcSEcCtD
Isoprenaline—Tension—Loratadine—atopic dermatitis	0.000462	0.00916	CcSEcCtD
Isoprenaline—Nervousness—Loratadine—atopic dermatitis	0.000457	0.00906	CcSEcCtD
Isoprenaline—Insomnia—Diphenhydramine—atopic dermatitis	0.000451	0.00894	CcSEcCtD
Isoprenaline—Insomnia—Dimenhydrinate—atopic dermatitis	0.000451	0.00894	CcSEcCtD
Isoprenaline—Angina pectoris—Tacrolimus—atopic dermatitis	0.00045	0.00891	CcSEcCtD
Isoprenaline—Dyspnoea—Pimecrolimus—atopic dermatitis	0.00043	0.00852	CcSEcCtD
Isoprenaline—Headache—Desonide—atopic dermatitis	0.000428	0.00848	CcSEcCtD
Isoprenaline—Pulmonary oedema—Prednisolone—atopic dermatitis	0.000418	0.00829	CcSEcCtD
Isoprenaline—Palpitations—Loratadine—atopic dermatitis	0.000416	0.00825	CcSEcCtD
Isoprenaline—Pulmonary oedema—Hydrocortisone—atopic dermatitis	0.000409	0.0081	CcSEcCtD
Isoprenaline—Hypertension—Loratadine—atopic dermatitis	0.000407	0.00806	CcSEcCtD
Isoprenaline—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.000399	0.0079	CcSEcCtD
Isoprenaline—Sweating—Tacrolimus—atopic dermatitis	0.000395	0.00782	CcSEcCtD
Isoprenaline—Pulmonary oedema—Triamcinolone—atopic dermatitis	0.000385	0.00762	CcSEcCtD
Isoprenaline—Pulmonary oedema—Methylprednisolone—atopic dermatitis	0.000384	0.00761	CcSEcCtD
Isoprenaline—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.00038	0.00753	CcSEcCtD
Isoprenaline—Tachycardia—Loratadine—atopic dermatitis	0.000375	0.00743	CcSEcCtD
Isoprenaline—Dizziness—Fluocinonide—atopic dermatitis	0.000366	0.00725	CcSEcCtD
Isoprenaline—Hypotension—Loratadine—atopic dermatitis	0.000359	0.00712	CcSEcCtD
Isoprenaline—Asthenia—Dimenhydrinate—atopic dermatitis	0.000358	0.00709	CcSEcCtD
Isoprenaline—Asthenia—Diphenhydramine—atopic dermatitis	0.000358	0.00709	CcSEcCtD
Isoprenaline—Pulmonary oedema—Dexamethasone—atopic dermatitis	0.000349	0.00692	CcSEcCtD
Isoprenaline—Pulmonary oedema—Betamethasone—atopic dermatitis	0.000349	0.00692	CcSEcCtD
Isoprenaline—Insomnia—Loratadine—atopic dermatitis	0.000348	0.00689	CcSEcCtD
Isoprenaline—Headache—Fluocinonide—atopic dermatitis	0.000347	0.00687	CcSEcCtD
Isoprenaline—PIK3R3—head—atopic dermatitis	0.000343	0.167	CbGeAlD
Isoprenaline—Flushing—Tacrolimus—atopic dermatitis	0.000343	0.0068	CcSEcCtD
Isoprenaline—Arrhythmia—Tacrolimus—atopic dermatitis	0.00033	0.00654	CcSEcCtD
Isoprenaline—Dizziness—Dimenhydrinate—atopic dermatitis	0.00033	0.00654	CcSEcCtD
Isoprenaline—Dizziness—Diphenhydramine—atopic dermatitis	0.00033	0.00654	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisolone—atopic dermatitis	0.000324	0.00643	CcSEcCtD
Isoprenaline—Cardiac arrest—Hydrocortisone—atopic dermatitis	0.000317	0.00628	CcSEcCtD
Isoprenaline—Tension—Tacrolimus—atopic dermatitis	0.000316	0.00625	CcSEcCtD
Isoprenaline—Headache—Dimenhydrinate—atopic dermatitis	0.000313	0.00619	CcSEcCtD
Isoprenaline—Headache—Diphenhydramine—atopic dermatitis	0.000313	0.00619	CcSEcCtD
Isoprenaline—Nervousness—Tacrolimus—atopic dermatitis	0.000312	0.00619	CcSEcCtD
Isoprenaline—MAPK1—skin of body—atopic dermatitis	0.000306	0.149	CbGeAlD
Isoprenaline—Pulmonary oedema—Prednisone—atopic dermatitis	0.000304	0.00602	CcSEcCtD
Isoprenaline—Vision blurred—Tacrolimus—atopic dermatitis	0.000303	0.00601	CcSEcCtD
Isoprenaline—Headache—Pimecrolimus—atopic dermatitis	0.000302	0.00599	CcSEcCtD
Isoprenaline—Tremor—Tacrolimus—atopic dermatitis	0.000301	0.00597	CcSEcCtD
Isoprenaline—Cardiac arrest—Triamcinolone—atopic dermatitis	0.000298	0.00591	CcSEcCtD
Isoprenaline—Cardiac arrest—Methylprednisolone—atopic dermatitis	0.000298	0.0059	CcSEcCtD
Isoprenaline—Nausea—Dimenhydrinate—atopic dermatitis	0.000296	0.00587	CcSEcCtD
Isoprenaline—Nausea—Diphenhydramine—atopic dermatitis	0.000296	0.00587	CcSEcCtD
Isoprenaline—Dyspnoea—Mometasone—atopic dermatitis	0.000294	0.00583	CcSEcCtD
Isoprenaline—Vertigo—Tacrolimus—atopic dermatitis	0.000289	0.00573	CcSEcCtD
Isoprenaline—Nausea—Pimecrolimus—atopic dermatitis	0.000287	0.00568	CcSEcCtD
Isoprenaline—Palpitations—Tacrolimus—atopic dermatitis	0.000284	0.00563	CcSEcCtD
Isoprenaline—Convulsion—Tacrolimus—atopic dermatitis	0.000279	0.00552	CcSEcCtD
Isoprenaline—Hypertension—Tacrolimus—atopic dermatitis	0.000278	0.0055	CcSEcCtD
Isoprenaline—Asthenia—Loratadine—atopic dermatitis	0.000276	0.00546	CcSEcCtD
Isoprenaline—Cardiac arrest—Betamethasone—atopic dermatitis	0.000271	0.00536	CcSEcCtD
Isoprenaline—Cardiac arrest—Dexamethasone—atopic dermatitis	0.000271	0.00536	CcSEcCtD
Isoprenaline—CYP1A1—skin epidermis—atopic dermatitis	0.000271	0.132	CbGeAlD
Isoprenaline—Bronchospasm—Methylprednisolone—atopic dermatitis	0.000266	0.00527	CcSEcCtD
Isoprenaline—Tachycardia—Tacrolimus—atopic dermatitis	0.000256	0.00508	CcSEcCtD
Isoprenaline—Dizziness—Loratadine—atopic dermatitis	0.000254	0.00504	CcSEcCtD
Isoprenaline—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.000254	0.00503	CcSEcCtD
Isoprenaline—Hypotension—Tacrolimus—atopic dermatitis	0.000245	0.00486	CcSEcCtD
Isoprenaline—Headache—Loratadine—atopic dermatitis	0.000241	0.00477	CcSEcCtD
Isoprenaline—Insomnia—Tacrolimus—atopic dermatitis	0.000237	0.0047	CcSEcCtD
Isoprenaline—Asthenia—Mometasone—atopic dermatitis	0.000237	0.00469	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisone—atopic dermatitis	0.000236	0.00467	CcSEcCtD
Isoprenaline—Dyspnoea—Tacrolimus—atopic dermatitis	0.000234	0.00464	CcSEcCtD
Isoprenaline—Sweating—Methylprednisolone—atopic dermatitis	0.000231	0.00458	CcSEcCtD
Isoprenaline—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000228	0.00453	CcSEcCtD
Isoprenaline—Nausea—Loratadine—atopic dermatitis	0.000228	0.00452	CcSEcCtD
Isoprenaline—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000216	0.00429	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisolone—atopic dermatitis	0.000211	0.00418	CcSEcCtD
Isoprenaline—Headache—Mometasone—atopic dermatitis	0.000207	0.00409	CcSEcCtD
Isoprenaline—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000206	0.00408	CcSEcCtD
Isoprenaline—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000205	0.00407	CcSEcCtD
Isoprenaline—ADRBK1—head—atopic dermatitis	0.000203	0.0988	CbGeAlD
Isoprenaline—MAPK1—head—atopic dermatitis	0.0002	0.0974	CbGeAlD
Isoprenaline—Nausea—Mometasone—atopic dermatitis	0.000196	0.00388	CcSEcCtD
Isoprenaline—Arrhythmia—Triamcinolone—atopic dermatitis	0.000194	0.00384	CcSEcCtD
Isoprenaline—Vision blurred—Prednisolone—atopic dermatitis	0.000194	0.00384	CcSEcCtD
Isoprenaline—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000193	0.00383	CcSEcCtD
Isoprenaline—Asthenia—Tacrolimus—atopic dermatitis	0.000188	0.00373	CcSEcCtD
Isoprenaline—Vertigo—Prednisolone—atopic dermatitis	0.000185	0.00366	CcSEcCtD
Isoprenaline—Vertigo—Hydrocortisone—atopic dermatitis	0.00018	0.00357	CcSEcCtD
Isoprenaline—Convulsion—Prednisolone—atopic dermatitis	0.000178	0.00353	CcSEcCtD
Isoprenaline—Hypertension—Prednisolone—atopic dermatitis	0.000177	0.00351	CcSEcCtD
Isoprenaline—Arrhythmia—Betamethasone—atopic dermatitis	0.000176	0.00349	CcSEcCtD
Isoprenaline—Arrhythmia—Dexamethasone—atopic dermatitis	0.000176	0.00349	CcSEcCtD
Isoprenaline—Convulsion—Hydrocortisone—atopic dermatitis	0.000174	0.00344	CcSEcCtD
Isoprenaline—Dizziness—Tacrolimus—atopic dermatitis	0.000174	0.00344	CcSEcCtD
Isoprenaline—Hypertension—Hydrocortisone—atopic dermatitis	0.000173	0.00343	CcSEcCtD
Isoprenaline—Vertigo—Triamcinolone—atopic dermatitis	0.00017	0.00336	CcSEcCtD
Isoprenaline—Vertigo—Methylprednisolone—atopic dermatitis	0.000169	0.00336	CcSEcCtD
Isoprenaline—Headache—Tacrolimus—atopic dermatitis	0.000164	0.00326	CcSEcCtD
Isoprenaline—Convulsion—Triamcinolone—atopic dermatitis	0.000164	0.00324	CcSEcCtD
Isoprenaline—Tachycardia—Prednisolone—atopic dermatitis	0.000164	0.00324	CcSEcCtD
Isoprenaline—Convulsion—Methylprednisolone—atopic dermatitis	0.000163	0.00324	CcSEcCtD
Isoprenaline—Hypertension—Triamcinolone—atopic dermatitis	0.000163	0.00323	CcSEcCtD
Isoprenaline—Hypertension—Methylprednisolone—atopic dermatitis	0.000163	0.00323	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000162	0.00321	CcSEcCtD
Isoprenaline—Tachycardia—Hydrocortisone—atopic dermatitis	0.00016	0.00317	CcSEcCtD
Isoprenaline—Flushing—Prednisone—atopic dermatitis	0.000159	0.00315	CcSEcCtD
Isoprenaline—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000158	0.00314	CcSEcCtD
Isoprenaline—Nausea—Tacrolimus—atopic dermatitis	0.000156	0.00309	CcSEcCtD
Isoprenaline—Vertigo—Betamethasone—atopic dermatitis	0.000154	0.00305	CcSEcCtD
Isoprenaline—Vertigo—Dexamethasone—atopic dermatitis	0.000154	0.00305	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisone—atopic dermatitis	0.000153	0.00304	CcSEcCtD
Isoprenaline—Hypotension—Hydrocortisone—atopic dermatitis	0.000153	0.00303	CcSEcCtD
Isoprenaline—Insomnia—Prednisolone—atopic dermatitis	0.000152	0.00301	CcSEcCtD
Isoprenaline—Tachycardia—Triamcinolone—atopic dermatitis	0.00015	0.00298	CcSEcCtD
Isoprenaline—Tachycardia—Methylprednisolone—atopic dermatitis	0.00015	0.00298	CcSEcCtD
Isoprenaline—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000149	0.00295	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000149	0.00295	CcSEcCtD
Isoprenaline—Convulsion—Betamethasone—atopic dermatitis	0.000149	0.00294	CcSEcCtD
Isoprenaline—Convulsion—Dexamethasone—atopic dermatitis	0.000149	0.00294	CcSEcCtD
Isoprenaline—Insomnia—Hydrocortisone—atopic dermatitis	0.000148	0.00293	CcSEcCtD
Isoprenaline—Hypertension—Dexamethasone—atopic dermatitis	0.000148	0.00293	CcSEcCtD
Isoprenaline—Hypertension—Betamethasone—atopic dermatitis	0.000148	0.00293	CcSEcCtD
Isoprenaline—Hypotension—Methylprednisolone—atopic dermatitis	0.000144	0.00285	CcSEcCtD
Isoprenaline—Vision blurred—Prednisone—atopic dermatitis	0.000141	0.00279	CcSEcCtD
Isoprenaline—Insomnia—Triamcinolone—atopic dermatitis	0.000139	0.00276	CcSEcCtD
Isoprenaline—Insomnia—Methylprednisolone—atopic dermatitis	0.000139	0.00276	CcSEcCtD
Isoprenaline—Dyspnoea—Triamcinolone—atopic dermatitis	0.000137	0.00272	CcSEcCtD
Isoprenaline—Tachycardia—Betamethasone—atopic dermatitis	0.000137	0.00271	CcSEcCtD
Isoprenaline—Tachycardia—Dexamethasone—atopic dermatitis	0.000137	0.00271	CcSEcCtD
Isoprenaline—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000135	0.00268	CcSEcCtD
Isoprenaline—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000135	0.00268	CcSEcCtD
Isoprenaline—Vertigo—Prednisone—atopic dermatitis	0.000134	0.00266	CcSEcCtD
Isoprenaline—Hypotension—Betamethasone—atopic dermatitis	0.000131	0.00259	CcSEcCtD
Isoprenaline—Hypotension—Dexamethasone—atopic dermatitis	0.000131	0.00259	CcSEcCtD
Isoprenaline—Convulsion—Prednisone—atopic dermatitis	0.000129	0.00256	CcSEcCtD
Isoprenaline—Hypertension—Prednisone—atopic dermatitis	0.000129	0.00255	CcSEcCtD
Isoprenaline—Insomnia—Betamethasone—atopic dermatitis	0.000127	0.00251	CcSEcCtD
Isoprenaline—Insomnia—Dexamethasone—atopic dermatitis	0.000127	0.00251	CcSEcCtD
Isoprenaline—Tachycardia—Prednisone—atopic dermatitis	0.000119	0.00236	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisone—atopic dermatitis	0.000118	0.00233	CcSEcCtD
Isoprenaline—Asthenia—Hydrocortisone—atopic dermatitis	0.000117	0.00233	CcSEcCtD
Isoprenaline—Dizziness—Prednisolone—atopic dermatitis	0.000111	0.0022	CcSEcCtD
Isoprenaline—Asthenia—Triamcinolone—atopic dermatitis	0.000111	0.00219	CcSEcCtD
Isoprenaline—Asthenia—Methylprednisolone—atopic dermatitis	0.00011	0.00219	CcSEcCtD
Isoprenaline—Insomnia—Prednisone—atopic dermatitis	0.00011	0.00218	CcSEcCtD
Isoprenaline—Dizziness—Hydrocortisone—atopic dermatitis	0.000108	0.00215	CcSEcCtD
Isoprenaline—Headache—Prednisolone—atopic dermatitis	0.000105	0.00208	CcSEcCtD
Isoprenaline—Headache—Hydrocortisone—atopic dermatitis	0.000103	0.00203	CcSEcCtD
Isoprenaline—Dizziness—Triamcinolone—atopic dermatitis	0.000102	0.00202	CcSEcCtD
Isoprenaline—Dizziness—Methylprednisolone—atopic dermatitis	0.000102	0.00202	CcSEcCtD
Isoprenaline—Asthenia—Betamethasone—atopic dermatitis	0.0001	0.00199	CcSEcCtD
Isoprenaline—Asthenia—Dexamethasone—atopic dermatitis	0.0001	0.00199	CcSEcCtD
Isoprenaline—Nausea—Prednisolone—atopic dermatitis	9.96e-05	0.00197	CcSEcCtD
Isoprenaline—Nausea—Hydrocortisone—atopic dermatitis	9.73e-05	0.00193	CcSEcCtD
Isoprenaline—Headache—Triamcinolone—atopic dermatitis	9.66e-05	0.00191	CcSEcCtD
Isoprenaline—Headache—Methylprednisolone—atopic dermatitis	9.64e-05	0.00191	CcSEcCtD
Isoprenaline—Dizziness—Betamethasone—atopic dermatitis	9.25e-05	0.00183	CcSEcCtD
Isoprenaline—Dizziness—Dexamethasone—atopic dermatitis	9.25e-05	0.00183	CcSEcCtD
Isoprenaline—Nausea—Triamcinolone—atopic dermatitis	9.16e-05	0.00181	CcSEcCtD
Isoprenaline—Nausea—Methylprednisolone—atopic dermatitis	9.14e-05	0.00181	CcSEcCtD
Isoprenaline—Headache—Dexamethasone—atopic dermatitis	8.76e-05	0.00174	CcSEcCtD
Isoprenaline—Headache—Betamethasone—atopic dermatitis	8.76e-05	0.00174	CcSEcCtD
Isoprenaline—Asthenia—Prednisone—atopic dermatitis	8.74e-05	0.00173	CcSEcCtD
Isoprenaline—ADRB1—head—atopic dermatitis	8.48e-05	0.0413	CbGeAlD
Isoprenaline—CYP1A1—skin of body—atopic dermatitis	8.38e-05	0.0409	CbGeAlD
Isoprenaline—Nausea—Dexamethasone—atopic dermatitis	8.31e-05	0.00165	CcSEcCtD
Isoprenaline—Nausea—Betamethasone—atopic dermatitis	8.31e-05	0.00165	CcSEcCtD
Isoprenaline—Dizziness—Prednisone—atopic dermatitis	8.06e-05	0.0016	CcSEcCtD
Isoprenaline—Headache—Prednisone—atopic dermatitis	7.63e-05	0.00151	CcSEcCtD
Isoprenaline—Nausea—Prednisone—atopic dermatitis	7.24e-05	0.00143	CcSEcCtD
Isoprenaline—CYP1A1—head—atopic dermatitis	5.47e-05	0.0267	CbGeAlD
Isoprenaline—ADRBK1—Immune System—NFKBIA—atopic dermatitis	1.67e-05	0.000127	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NGF—atopic dermatitis	1.66e-05	0.000127	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CXCL10—atopic dermatitis	1.66e-05	0.000127	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL5—atopic dermatitis	1.66e-05	0.000127	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TAC1—atopic dermatitis	1.66e-05	0.000127	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NPS—atopic dermatitis	1.66e-05	0.000127	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—CXCL8—atopic dermatitis	1.66e-05	0.000126	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by NGF—IL6—atopic dermatitis	1.65e-05	0.000126	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—IL6—atopic dermatitis	1.65e-05	0.000126	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR in disease—IL6—atopic dermatitis	1.65e-05	0.000126	CbGpPWpGaD
Isoprenaline—MAPK1—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	1.65e-05	0.000126	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL17—atopic dermatitis	1.65e-05	0.000126	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CXCL10—atopic dermatitis	1.64e-05	0.000125	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CXCR3—atopic dermatitis	1.64e-05	0.000125	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR—IL6—atopic dermatitis	1.63e-05	0.000125	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—TAC1—atopic dermatitis	1.63e-05	0.000124	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—NPS—atopic dermatitis	1.63e-05	0.000124	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IFNG—atopic dermatitis	1.63e-05	0.000124	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CXCR3—atopic dermatitis	1.63e-05	0.000124	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR in Cancer—IL6—atopic dermatitis	1.62e-05	0.000124	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CCR5—atopic dermatitis	1.62e-05	0.000124	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by PDGF—IL6—atopic dermatitis	1.61e-05	0.000123	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CXCR3—atopic dermatitis	1.6e-05	0.000122	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—NFKBIA—atopic dermatitis	1.6e-05	0.000122	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CMA1—atopic dermatitis	1.59e-05	0.000121	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL11—atopic dermatitis	1.59e-05	0.000121	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.59e-05	0.000121	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—TLR2—atopic dermatitis	1.59e-05	0.000121	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—IL6—atopic dermatitis	1.59e-05	0.000121	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—IL2—atopic dermatitis	1.58e-05	0.000121	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL5—atopic dermatitis	1.58e-05	0.000121	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CD4—atopic dermatitis	1.57e-05	0.00012	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.55e-05	0.000118	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CXCL10—atopic dermatitis	1.55e-05	0.000118	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL5—atopic dermatitis	1.55e-05	0.000118	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL5—atopic dermatitis	1.54e-05	0.000118	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CASP8—atopic dermatitis	1.53e-05	0.000116	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL5—atopic dermatitis	1.52e-05	0.000116	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CASP8—atopic dermatitis	1.5e-05	0.000115	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KIF3A—atopic dermatitis	1.5e-05	0.000114	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—STAT6—atopic dermatitis	1.5e-05	0.000114	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CCR5—atopic dermatitis	1.49e-05	0.000114	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD79A—atopic dermatitis	1.49e-05	0.000114	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—PPARA—atopic dermatitis	1.48e-05	0.000113	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—MAPK8—atopic dermatitis	1.48e-05	0.000113	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KIF3A—atopic dermatitis	1.47e-05	0.000112	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	1.46e-05	0.000111	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—IL6—atopic dermatitis	1.46e-05	0.000111	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.46e-05	0.000111	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.45e-05	0.000111	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL1B—atopic dermatitis	1.45e-05	0.000111	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—CD4—atopic dermatitis	1.45e-05	0.000111	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL2—atopic dermatitis	1.45e-05	0.00011	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CASP8—atopic dermatitis	1.44e-05	0.00011	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.43e-05	0.000109	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CCL5—atopic dermatitis	1.43e-05	0.000109	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CXCL10—atopic dermatitis	1.42e-05	0.000109	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.41e-05	0.000108	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CCL5—atopic dermatitis	1.41e-05	0.000108	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GLB1—atopic dermatitis	1.39e-05	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—IL2—atopic dermatitis	1.39e-05	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NFKBIA—atopic dermatitis	1.37e-05	0.000105	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—NFKBIA—atopic dermatitis	1.37e-05	0.000105	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—IL2—atopic dermatitis	1.37e-05	0.000104	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CMA1—atopic dermatitis	1.36e-05	0.000103	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL11—atopic dermatitis	1.36e-05	0.000103	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CXCL10—atopic dermatitis	1.35e-05	0.000103	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CCL5—atopic dermatitis	1.34e-05	0.000102	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ADSL—atopic dermatitis	1.34e-05	0.000102	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—MAPK8—atopic dermatitis	1.33e-05	0.000102	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CMA1—atopic dermatitis	1.33e-05	0.000101	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL11—atopic dermatitis	1.33e-05	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NGF—atopic dermatitis	1.33e-05	0.000101	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CXCL10—atopic dermatitis	1.32e-05	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—CXCL8—atopic dermatitis	1.32e-05	0.000101	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CXCL10—atopic dermatitis	1.32e-05	0.0001	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NGF—atopic dermatitis	1.31e-05	9.97e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—CXCL8—atopic dermatitis	1.3e-05	9.92e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IFNG—atopic dermatitis	1.3e-05	9.9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCR3—atopic dermatitis	1.3e-05	9.9e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CXCL10—atopic dermatitis	1.29e-05	9.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CCR5—atopic dermatitis	1.29e-05	9.85e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IFNG—atopic dermatitis	1.28e-05	9.75e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—STAT6—atopic dermatitis	1.27e-05	9.73e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CCR5—atopic dermatitis	1.27e-05	9.7e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—IL2—atopic dermatitis	1.26e-05	9.63e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CD4—atopic dermatitis	1.25e-05	9.56e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CCL5—atopic dermatitis	1.25e-05	9.56e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—STAT6—atopic dermatitis	1.25e-05	9.52e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL2—atopic dermatitis	1.24e-05	9.49e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CASP8—atopic dermatitis	1.24e-05	9.43e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CD4—atopic dermatitis	1.23e-05	9.42e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CCL5—atopic dermatitis	1.23e-05	9.35e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL18—atopic dermatitis	1.22e-05	9.31e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—IL2—atopic dermatitis	1.21e-05	9.24e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—CXCL8—atopic dermatitis	1.21e-05	9.22e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CCR5—atopic dermatitis	1.2e-05	9.18e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD8A—atopic dermatitis	1.2e-05	9.17e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PPARA—atopic dermatitis	1.2e-05	9.15e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—IL6—atopic dermatitis	1.2e-05	9.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CD4—atopic dermatitis	1.19e-05	9.04e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—CXCL8—atopic dermatitis	1.18e-05	9.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.18e-05	8.99e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—IL6—atopic dermatitis	1.16e-05	8.88e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCL5—atopic dermatitis	1.16e-05	8.85e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL1B—atopic dermatitis	1.16e-05	8.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CD4—atopic dermatitis	1.16e-05	8.83e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TAC1—atopic dermatitis	1.16e-05	8.82e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NPS—atopic dermatitis	1.16e-05	8.82e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL2—atopic dermatitis	1.15e-05	8.8e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.15e-05	8.77e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—IL6—atopic dermatitis	1.15e-05	8.75e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—IL6—atopic dermatitis	1.14e-05	8.72e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL1B—atopic dermatitis	1.14e-05	8.7e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CD4—atopic dermatitis	1.14e-05	8.7e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCL5—atopic dermatitis	1.14e-05	8.68e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL2—atopic dermatitis	1.14e-05	8.67e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCR3—atopic dermatitis	1.13e-05	8.65e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCL5—atopic dermatitis	1.13e-05	8.64e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CCR5—atopic dermatitis	1.13e-05	8.61e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—IL2—atopic dermatitis	1.13e-05	8.59e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—IL6—atopic dermatitis	1.12e-05	8.57e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCL5—atopic dermatitis	1.11e-05	8.49e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCR3—atopic dermatitis	1.11e-05	8.43e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CCR5—atopic dermatitis	1.1e-05	8.43e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—IL2—atopic dermatitis	1.1e-05	8.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NFKBIA—atopic dermatitis	1.09e-05	8.35e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR3—atopic dermatitis	1.08e-05	8.25e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NFKBIA—atopic dermatitis	1.08e-05	8.22e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NGF—atopic dermatitis	1.07e-05	8.2e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL5—atopic dermatitis	1.07e-05	8.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—CXCL8—atopic dermatitis	1.07e-05	8.16e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—MAPK8—atopic dermatitis	1.06e-05	8.1e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IFNG—atopic dermatitis	1.05e-05	8.02e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NGF—atopic dermatitis	1.05e-05	8e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—MAPK8—atopic dermatitis	1.05e-05	7.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCR5—atopic dermatitis	1.05e-05	7.98e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—CXCL8—atopic dermatitis	1.04e-05	7.97e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCR5—atopic dermatitis	1.03e-05	7.82e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL2—atopic dermatitis	1.02e-05	7.8e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCR5—atopic dermatitis	1.02e-05	7.79e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—IL6—atopic dermatitis	1.02e-05	7.76e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD4—atopic dermatitis	1.02e-05	7.75e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.01e-05	7.74e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CCR5—atopic dermatitis	1.01e-05	7.74e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—MAPK8—atopic dermatitis	1e-05	7.66e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCR5—atopic dermatitis	1e-05	7.65e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL2—atopic dermatitis	9.98e-06	7.62e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NPS—atopic dermatitis	9.85e-06	7.52e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TAC1—atopic dermatitis	9.85e-06	7.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CXCL8—atopic dermatitis	9.79e-06	7.47e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCR3—atopic dermatitis	9.66e-06	7.37e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TAC1—atopic dermatitis	9.64e-06	7.35e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NPS—atopic dermatitis	9.64e-06	7.35e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCR3—atopic dermatitis	9.45e-06	7.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—IL6—atopic dermatitis	9.43e-06	7.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL1B—atopic dermatitis	9.38e-06	7.16e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CD4—atopic dermatitis	9.38e-06	7.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL2—atopic dermatitis	9.35e-06	7.14e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL2—atopic dermatitis	9.34e-06	7.13e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—NFKBIA—atopic dermatitis	9.32e-06	7.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—IL6—atopic dermatitis	9.31e-06	7.1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL10—atopic dermatitis	9.16e-06	6.99e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL5—atopic dermatitis	9.16e-06	6.99e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TNF—atopic dermatitis	8.99e-06	6.86e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL5—atopic dermatitis	8.96e-06	6.84e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NFKBIA—atopic dermatitis	8.86e-06	6.76e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NFKBIA—atopic dermatitis	8.65e-06	6.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MAPK8—atopic dermatitis	8.61e-06	6.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—MAPK8—atopic dermatitis	8.6e-06	6.56e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL6—atopic dermatitis	8.5e-06	6.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CASP8—atopic dermatitis	8.41e-06	6.41e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL5—atopic dermatitis	7.89e-06	6.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—IL6—atopic dermatitis	7.85e-06	5.99e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL10—atopic dermatitis	7.81e-06	5.96e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CXCL8—atopic dermatitis	7.8e-06	5.95e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CXCL8—atopic dermatitis	7.68e-06	5.86e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL10—atopic dermatitis	7.64e-06	5.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL2—atopic dermatitis	7.46e-06	5.69e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—IL6—atopic dermatitis	7.42e-06	5.66e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL2—atopic dermatitis	7.34e-06	5.6e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL6—atopic dermatitis	7.31e-06	5.58e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NGF—atopic dermatitis	7.31e-06	5.57e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CXCL8—atopic dermatitis	7.27e-06	5.55e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—IL6—atopic dermatitis	7.26e-06	5.54e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IFNG—atopic dermatitis	7.15e-06	5.45e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCR5—atopic dermatitis	7.11e-06	5.42e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL2—atopic dermatitis	6.95e-06	5.3e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD4—atopic dermatitis	6.9e-06	5.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MAPK8—atopic dermatitis	6.86e-06	5.24e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	6.83e-06	5.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL6—atopic dermatitis	6.78e-06	5.17e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MAPK8—atopic dermatitis	6.76e-06	5.16e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	6.72e-06	5.13e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CXCL8—atopic dermatitis	6.68e-06	5.09e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—atopic dermatitis	6.68e-06	5.09e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL5—atopic dermatitis	6.58e-06	5.02e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	6.52e-06	4.98e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—atopic dermatitis	6.41e-06	4.89e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—IL2—atopic dermatitis	6.38e-06	4.87e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—atopic dermatitis	6.37e-06	4.86e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CD4—atopic dermatitis	6.37e-06	4.86e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL2—atopic dermatitis	6.35e-06	4.85e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CXCL8—atopic dermatitis	6.32e-06	4.82e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—atopic dermatitis	6.26e-06	4.77e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NGF—atopic dermatitis	6.23e-06	4.75e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	6.2e-06	4.73e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CXCL8—atopic dermatitis	6.17e-06	4.71e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—atopic dermatitis	6.16e-06	4.7e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NGF—atopic dermatitis	6.09e-06	4.65e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CXCL8—atopic dermatitis	6.06e-06	4.63e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	6.06e-06	4.62e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL2—atopic dermatitis	6.04e-06	4.61e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NFKBIA—atopic dermatitis	6.02e-06	4.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—atopic dermatitis	6.01e-06	4.59e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR5—atopic dermatitis	5.92e-06	4.52e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	5.92e-06	4.52e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL2—atopic dermatitis	5.9e-06	4.5e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—atopic dermatitis	5.87e-06	4.48e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MAPK8—atopic dermatitis	5.85e-06	4.46e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL2—atopic dermatitis	5.79e-06	4.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK8—atopic dermatitis	5.56e-06	4.24e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—atopic dermatitis	5.5e-06	4.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—atopic dermatitis	5.49e-06	4.19e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK8—atopic dermatitis	5.43e-06	4.14e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	5.13e-06	3.92e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—atopic dermatitis	5.07e-06	3.87e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NFKBIA—atopic dermatitis	5.02e-06	3.83e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARA—atopic dermatitis	4.52e-06	3.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—atopic dermatitis	4.38e-06	3.34e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—atopic dermatitis	4.32e-06	3.29e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL8—atopic dermatitis	4.3e-06	3.28e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL2—atopic dermatitis	4.11e-06	3.13e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—atopic dermatitis	4.09e-06	3.12e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAPK8—atopic dermatitis	3.78e-06	2.88e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—atopic dermatitis	3.73e-06	2.85e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	3.66e-06	2.79e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL8—atopic dermatitis	3.58e-06	2.73e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—atopic dermatitis	3.55e-06	2.71e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL2—atopic dermatitis	3.5e-06	2.67e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	3.48e-06	2.66e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—atopic dermatitis	3.47e-06	2.64e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—atopic dermatitis	3.45e-06	2.63e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL2—atopic dermatitis	3.42e-06	2.61e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—atopic dermatitis	3.41e-06	2.6e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	3.22e-06	2.46e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK8—atopic dermatitis	3.15e-06	2.4e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—atopic dermatitis	2.41e-06	1.84e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—atopic dermatitis	2.06e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—atopic dermatitis	2.01e-06	1.54e-05	CbGpPWpGaD
